SCHEMBL6069116

SCHEMBL6069116

CC[C@H](COCc1ccccc1)C(=O)N1C(=O)OC[C@H]1Cc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 1/20 0.43
IL6ST P40189 1/20 0.39
SLC1A1 P43005 1/20 0.39
FAAH O00519 1/20 0.39
NAAA Q02083 1/20 0.38
ALDH1A1 P00352 1/20 0.38
PSMB11 A5LHX3 1/20 0.37
PSMD11 O00231 1/20 0.37
PSMD12 O00232 1/20 0.37
PSMD14 O00487 1/20 0.37
PSMA7 O14818 1/20 0.37
PSMD3 O43242 1/20 0.37
PSMC3 P17980 1/20 0.37
PSMB1 P20618 1/20 0.37
PSMA1 P25786 1/20 0.37
PSMA2 P25787 1/20 0.37
PSMA3 P25788 1/20 0.37
PSMA4 P25789 1/20 0.37
PSMB8 P28062 1/20 0.37
PSMB9 P28065 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6068526 1.00 PPARA (0.43) PPARAIL6STSLC1A1FAAHNAAA
SCHEMBL6068528 1.00 PPARA (0.43) PPARAIL6STSLC1A1FAAHNAAA
SCHEMBL6668597 0.92 PPARA (0.44) PPARAIL6STSLC1A1FAAHNAAA
SCHEMBL6668336 0.92 PPARA (0.44) PPARAIL6STSLC1A1FAAHNAAA
SCHEMBL6668331 0.92 PPARA (0.44) PPARAIL6STSLC1A1FAAHNAAA
SCHEMBL13103436 0.90 PPARA (0.42) PPARAIL6STSLC1A1FAAHNAAA
SCHEMBL8887105 0.90 PPARA (0.46) PPARAIL6STSLC1A1FAAHNAAA
SCHEMBL8811308 0.90 PPARA (0.46) PPARAIL6STSLC1A1FAAHNAAA
SCHEMBL132735 0.89 PPARA (0.47) PPARAIL6STSLC1A1FAAHNAAA
SCHEMBL132736 0.89 PPARA (0.47) PPARAIL6STSLC1A1FAAHNAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7109234-B2 Benzoxathiepine derivatives and their use as medicines PIERRE FABRE MEDICAMENT (FR) 2006-09-19 US disclosed
EP-1370547-B1 BENZOAXATHIEPIN DERIVATIVES AND THEIR USE AS MEDICINES PF MEDICAMENT (FR) 2004-09-15 EP disclosed
US-20040127552-A1 Benzoaxathiepin derivatives and their use as medicines PIERRE FABRE MEDICAMENT (FR) 2004-07-01 US disclosed
EP-1370547-A1 BENZOAXATHIEPIN DERIVATIVES AND THEIR USE AS MEDICINES PIERRE FABRE MEDICAMENT (FR) 2003-12-17 EP disclosed
WO-2002081464-A1 BENZOAXATHIEPIN DERIVATIVES AND THEIR USE AS MEDICINES PIERRE FABRE MEDICAMENT (FR) 2002-10-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127552-A1 Benzoaxathiepin derivatives and their use as medicines CYP4A11, CYP3A4, CYP4F11 PPARA 1111/4885IL6ST 1873/4885SLC1A1 1152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.